You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0556 Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Infection-related rheumatic diseases
SAT0556 Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20173000
Jul 2017400
Aug 2017801
Sep 20171001
Oct 20172203
Nov 2017200
Dec 2017800
Jan 20181004
Feb 20182602
Mar 20181001
Apr 201832012
May 2018400
Jun 20181402
Jul 2018400
Aug 20182003
Sep 2018001
Oct 2018601
Nov 2018203
Dec 2018403
Jan 2019804
Feb 2019401
Mar 2019003
Apr 2019605
May 2019002
Jun 2019202
Jul 2019604
Aug 2019402
Oct 20191003
Nov 2019002
Dec 2019403
Jan 2020202
Mar 2020001
Apr 2020001
May 2020801
Jun 2020804
Jul 2020602
Aug 2020201
Sep 2020800
Oct 2020203
Nov 2020200
Dec 2020401
Jan 2021001
Feb 2021002
Mar 2021002
Apr 2021202
May 2021001
Jun 2021001
Jul 2021004
Aug 2021002
Sep 2021004
Oct 20210014
Nov 202134010
Dec 20218801
Jan 20227600
Feb 20228401
Mar 20223001
Apr 20221001
May 20222107
Jun 20222402
Jul 20224200
Aug 20226202
Sep 20226007
Oct 20223403
Nov 20222808
Dec 20222600
Jan 2023602
Feb 2023200
Mar 20234200
Apr 20231602
May 2023402
Jul 2023404
Aug 2023001
Oct 2023201
Nov 20232060
Dec 2023600
Jan 2024800
Feb 2024802
Mar 20244020
Total10270254